Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology

Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology

Abstract Background Glioblastoma (GBM) is a highly aggressive primary brain cancer, for which curative therapies are not available. An emerging therapeutic approach suggested to have potential to target malignant gliomas has been based on the use of multipotent mesenchymal stem cells (MSCs), either...

Full description

Bibliographic Details
Main Authors: Joana Vieira de Castro, Eduardo D. Gomes, Sara Granja, Sandra I. Anjo, Fátima Baltazar, Bruno Manadas, António J. Salgado, Bruno M. Costa
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Journal of Translational Medicine
Subjects:
Glioblastoma
Mesenchymal stem cells
Human umbilical cord perivascular cells
Conditioned media
Secretome
Viability
Online Access:http://link.springer.com/article/10.1186/s12967-017-1303-8

Internet

http://link.springer.com/article/10.1186/s12967-017-1303-8

Similar Items